Pelemed Co., Ltd. is a South Korean company located in Seoul that develops drugs for treatment of intractable cancer, neurological & immune diseases. It was founded in 2019. Soo-Yeon Jang and Yong-Chul Kim are the current co-CEOs of the firm. With expertise in medical devices and technology, Pelemed strives to deliver high-quality products and services to customers worldwide.

Disease Domain	Count

Neoplasms	10
Hemic and Lymphatic Diseases	4
Infectious Diseases	2

Top 5 Drug Type	Count

Small molecule drug	9
Chemical drugs	2
Antibody drug conjugate (ADC)	1

Top 5 Target	Count

EGFR(Epidermal growth factor receptor erbB1)	1
FLT3(Tyrosine-protein kinase receptor FLT3)	1
HBV capsid	1
TEAD(TEA domain transcription factors)	1
Protein kinases	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 13 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 1 Clinical

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

PLD-401	Hepatitis B, Chronic More	Phase 1
PLD-102	Acute Myeloid Leukemia with FLT3/ITD Mutation More	Phase 1
PLM-101 ( EGFR )	Non-Small Cell Lung Cancer More	Preclinical
PLM-102 ( FLT3 x RET )	Acute Myeloid Leukemia More	Preclinical
LDD-5557 ( TPST2 )	Neoplasms More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis